A painful inflammation of the pancreas called acute pancreatitis is a potential new safety issue identified with the new class of type 2 diabetes treatments known as SGLT2 inhibitors. The side effect was identified through the Food and Drug Administration (FDA) adverse event tracking database, which identifies potential hazards with drugs each quarter. The FDA identifies potentially harmful side effects with medications to determine if further action – such as additional or strengthened warnings – are required. The agency said it is currently evaluating the need for regulatory action regarding the link between SGLT2 inhibitors and acute pancreatitis. SGLT2 inhibitors ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.